alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
**COURT OF APPEALS**

**TENTH DISTRICT OF TEXAS**

****

December 17, 2015

No. 10-14-00308-CR

ANDRIA ANTIONETTE HARRIS

v.

THE STATE OF TEXAS

_______________

From the County Court at Law No. 1

Brazos County, Texas

Trial Court No. 12-03413-CRM-CCL1

**JUDGMENT**

	This Court has reviewed the briefs of the parties and the record in this proceeding as relevant to the issue raised and finds no reversible error is presented.  Accordingly the trial court’s judgment signed on August 6, 2014 is affirmed.

	A copy of this judgment will be certified by the Clerk of this Court and delivered to the trial court clerk for enforcement.

							PER CURIAM

****SHARRI ROESSLER, CLERK

						By: ___________________________

							Nita Whitener, Deputy Clerk

# image1.png

# image2.jpeg

# image3.png
# Third District Court of Appeal State of Florida Opinion filed September 18, 2024

. Not final until disposition of timely filed motion for rehearing.

________________ No. 3D23

- 22 9 5 Lower Tribunal No. 1 9

- 22194

________________


### Emmanuel Pacin , Appellant,

vs. 

### Nicole Granja , Appellee.

An Appeal from a non - final order from the Circuit Court for Miami

- Dade County, Marcia Del Rey , Judge. Rhonda F. Goodman , P.A., and Rhonda F. Goodman , for appellant. Abramowitz and Associates, and Jordan B. Abramowitz , for appellee.

Before E MA S, SCALES , and GO O D EN , JJ. SCALES, J.2

Appellant Emmanuel Pacin (Father) seeks appellate review of a November 22, 2023 order dismissing Father’s May 1, 2023 amended supplemental petition for modification of a final judgment of parental responsibility, timesharing, and child support (amended sup plemental petition). Appellee Nicole Granja (Mother) moved to dismiss Father’s amended supplemental petition, asserting that Father had failed to allege sufficient facts entitling Father to relief and that Father had “unclean hands” barring Father’s attempt to modify his obli gations. After conducting an October 9, 2023 hearing on Mother’s dismissal motion, the trial court entered the challenged order that dismissed Father’s amended supplemental petition without prejudice to file a second amended supplemental petition within twenty day s of the order. While the trial court addressed the bases upon which Mother’s dismissal motion was premised, the record is clear that the trial court contemplated Father filing an amended pleading rather than a new case. The challenged order, therefore,

co nstitutes a non

- final, non

- appealable order. Obermark v. Obermark , 48. Fla. L. Weekly D 1891, 2023 WL 6165646, at *1 (Fla. 5th DCA Sept. 22, 2023).3

Without expressing any opinion as to whether the trial court erred in entering the challenged order, we dismiss the appeal for lack of jurisdiction. Appeal dismissed.
```

[Congressional Bills 108th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 270 Engrossed in House (EH)]

                 In the House of Representatives, U.S.,

                                                         June 12, 2003.
    Resolved, That upon adoption of this resolution the bill (H.R. 1308) to 
amend the Internal Revenue Code of 1986 to end certain abusive tax practices, to 
provide tax relief and simplification, and for other purposes, with the Senate 
amendments thereto, be, and the same are hereby, taken from the Speaker's table 
to the ends that the Senate amendment to the title be, and the same is hereby, 
agreed to, and the Senate amendment to the text be, and the same is hereby, 
agreed to with the amendment printed in the report of the Committee on Rules 
accompanying this resolution.
    Sec. 2. It shall be in order for the chairman of the Committee on Ways and 
Means to move that the House insist on its amendment to the Senate amendment to 
H.R. 1308, or that the House disagree to any further Senate amendment, and 
request or agree to a conference with the Senate thereon.
            Attest:

                                                                          Clerk.
```
Exhibit 13.2

Kowloon-Canton Railway Corporation

Certification Pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002

(18 U.S.C. Section 1350)

Pursuant to the requirements of Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. Sections 1350(a) and (b)), the undersigned hereby certifies
as follows:



|1. | I, Lawrence C.P. Li, am the Director, Finance, of Kowloon-Canton Railway Corporation (the Corporation).
|-- | ---------------------------------------------------------------------------------------------------------



|2. | To my knowledge:
|-- | ----------------



| | (A) | The Corporations Form 20-F accompanying this Certification, in the form filed with the Securities and Exchange Commission (the Report) fully complies with the
requirements of Section 13(a) of the Securities Exchange Act of 1934 (the Exchange Act); and
| | --- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| | (B) | The information in the Report fairly presents, in all material respects, the financial condition and results of operations of the Corporation.
| | --- | ----------------------------------------------------------------------------------------------------------------------------------------------

Dated: July 14, 2006



/s/ Lawrence C.P. LiName:

Lawrence C.P. LiTitle:

Director, Finance


A SIGNED ORIGINAL OF THIS WRITTEN STATEMENT REQUIRED BY SECTION 906 OF THE SARBANES-OXLEY ACT HAS BEEN
PROVIDED TO KOWLOON-CANTON RAILWAY CORPORATION AND WILL BE RETAINED BY KOWLOON-CANTON RAILWAY CORPORATION AND FURNISHED TO THE SECURITIES AND EXCHANGE COMMISSION OR ITS STAFF UPON REQUEST.
H. Res. 168

In the House of Representatives, U.S.,

April 2, 2003.

Resolved, That upon the adoption of this resolution it

shall be in order without intervention of any point of order

to consider in the House the bill (H.R. 743) to amend the

Social Security Act and the Internal Revenue Code of 1986

to provide additional safeguards for Social Security and Supplemental Security Income beneficiaries with representative

payees, to enhance program protections, and for other purposes. The bill shall be considered as read for amendment.

The amendment recommended by the Committee on Ways

and Means now printed in the bill shall be considered as

adopted. The previous question shall be considered as ordered

on the bill, as amended, and on any further amendment

thereto to final passage without intervening motion except:

(1) one hour of debate on the bill, as amended, equally divided and controlled by the chairman and ranking minority

member of the Committee on Ways and Means; (2) the further amendment printed in the report of the Committee on

Rules accompanying this resolution, if offered by Representa-
2

•HRES 168 EH

tive Green of Texas or his designee, which shall be in order

without intervention of any point of order, shall be considered

as read, and shall be separately debatable for 40 minutes

equally divided and controlled by the proponent and an opponent; and (3) one motion to recommit with or without instructions.

Attest:

Clerk.
**Exhibit 32.1**

**CEO CERTIFICATION PURSUANT TO18 U.S.C. SECTION 1350,AS ADOPTED PURSUANT TOSECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with the Quarterly Report of Focus Enhancements, Inc.(the “Company”) on Form 10-Q for the period ended June 30, 2007, as filedwith the Securities and Exchange Commission on the date hereof (the “Report”),I, Brett Moyer, President and Chief Executive Officer of the Company, certify,pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 ofthe Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

(1)   The Report fully complies with therequirements of section 13(a) or 15(d) of the Securities Exchange Act of1934; and

(2)   The information contained in the Reportfairly presents, in all material respects, the financial condition and resultof operations of the Company.
| /s/ Brett A. Moyer      |   |
|-------------------------|--------|
|                    |
| Brett A. Moyer          |
| Chief Executive Officer |
| August 13, 2007         |

 

----
<TABLE> <S> <C>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-START>                             JAN-01-1998
<PERIOD-END>                               MAR-31-1998
<CASH>                                         510,642
<SECURITIES>                                         0
<RECEIVABLES>                                5,397,007
<ALLOWANCES>                                   158,000
<INVENTORY>                                    434,508
<CURRENT-ASSETS>                             6,832,521
<PP&E>                                      10,873,094
<DEPRECIATION>                               1,546,796
<TOTAL-ASSETS>                              34,260,536
<CURRENT-LIABILITIES>                       11,996,708
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                        289
<COMMON>                                         5,177
<OTHER-SE>                                           0
<TOTAL-LIABILITY-AND-EQUITY>                34,260,536
<SALES>                                              0
<TOTAL-REVENUES>                             6,082,786
<CGS>                                        5,702,247
<TOTAL-COSTS>                                7,144,902
<OTHER-EXPENSES>                                79,903
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             280,000
<INCOME-PRETAX>                             (1,421,619)
<INCOME-TAX>                                  (478,555)
<INCOME-CONTINUING>                           (943,064)
<DISCONTINUED>                                  14,102
<EXTRAORDINARY>                               (928,962)
<CHANGES>                                            0
<NET-INCOME>                                  (928,962)
<EPS-BASIC>                                       (.21)
<EPS-DILUTED>                                     (.21)


</TABLE>
WARNING: THE EDGAR SYSTEM ENCOUNTERED ERROR(S) WHILE PROCESSING THIS SCHEDULE.

<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                                <C>
<PERIOD-TYPE>                      12-MOS
<FISCAL-YEAR-END>                  DEC-31-1996
<PERIOD-START>                     JAN-01-1996
<PERIOD-END>                       DEC-31-1996
<CASH>                               159922
<SECURITIES>                              0
<RECEIVABLES>                        196057
<ALLOWANCES>                          11618
<INVENTORY>                          182849
<CURRENT-ASSETS>                     580438
<PP&E>                             11863027
<DEPRECIATION>                      3377316
<TOTAL-ASSETS>                     10270480
<CURRENT-LIABILITIES>               2303743
<BONDS>                                   0
<COMMON>                             401201
<PREFERRED-MANDATORY>                     0
<PREFERRED>                               0
<OTHER-SE>                                0
<TOTAL-LIABILITY-AND-EQUITY>       10270480
<SALES>                             8582911
<TOTAL-REVENUES>                    8587856
<CGS>                                     0
<TOTAL-COSTS>                       8951731
<OTHER-EXPENSES>                          0
<LOSS-PROVISION>
<INTEREST-EXPENSE>                   699929
<INCOME-PRETAX>                     (363875)
<INCOME-TAX>                              0
<INCOME-CONTINUING>                 (363875)
<DISCONTINUED>                            0
<EXTRAORDINARY>                           0
<CHANGES>                                 0
<NET-INCOME>                        (363875)
<EPS-PRIMARY>                             0
<EPS-DILUTED>                        (.0283)
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         Center for Scientific Review Special Emphasis Panel, PAR Panel: Linking Provider Recommendation to Adolescent HPV Uptake.                    

*Date:*                         September 12, 2017.                    

*Time:*                         12:00 p.m. to 4:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call).                    

*Contact Person:*                         Tasmeen Weik, DRPH, MPH, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3141, Bethesda, MD 20892, 301-827-6480,                         *weikts@mail.nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, National Institutes of Health, HHS)

Dated: August 9, 2017.

Natasha M. Copeland,

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2017-17154 Filed 8-14-17; 8:45 am]

 BILLING CODE 4140-01-P
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONSOLIDATED BALANCE SHEET AND CONSOLIDATED STATEMENT OF OPERATIONS FILED AS
PART OF THE QUARTERLY REPORT ON FORM 10-Q AND IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO SUCH QUARTERLY REPORT ON FORM 10-Q FOR THE QUARTERLY PERIOD ENDED
SEPTEMBER 30, 1996.
</LEGEND>
<MULTIPLIER> 1
<CURRENCY> U.S. CURRENCY
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-START>                             JAN-01-1996
<PERIOD-END>                               SEP-30-1996
<EXCHANGE-RATE>                                      1
<CASH>                                       2,613,000
<SECURITIES>                                         0
<RECEIVABLES>                               21,363,000
<ALLOWANCES>                                         0
<INVENTORY>                                  2,144,000
<CURRENT-ASSETS>                            32,739,000
<PP&E>                                       7,651,000
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                              67,476,000
<CURRENT-LIABILITIES>                       28,645,000
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        90,000
<OTHER-SE>                                  36,198,000
<TOTAL-LIABILITY-AND-EQUITY>                67,476,000
<SALES>                                     67,836,000
<TOTAL-REVENUES>                            67,836,000
<CGS>                                       54,608,000
<TOTAL-COSTS>                               54,608,000
<OTHER-EXPENSES>                            23,491,000
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             334,000
<INCOME-PRETAX>                             (2,637,000)
<INCOME-TAX>                                   761,000
<INCOME-CONTINUING>                         (3,398,000)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                (3,398,000)
<EPS-PRIMARY>                                     (.38)
<EPS-DILUTED>                                        0
        

</TABLE>
IN THE SUPREME COURT OF THE STATE OF DELAWARE

BTG INTERNATIONAL INC., §

§

Plaintiff, Counterclaim § No. 509, 2017

Defendant Below, §

Appellant, § Court Below: Court of Chancery

§ of the State of Delaware

v. §

§ C.A. No. 12562-VCL

WELLSTAT THERAPEUTICS §

CORPORATION, §

§

Defendant, Counterclaim §

Plaintiff Below, §

Appellee. §

Submitted: June 6, 2018

Decided: June 11, 2018

Before STRINE, Chief Justice; VALIHURA, VAUGHN, SEITZ, and 

TRAYNOR, Justices, constituting the Court en Banc.

O R D E R

In this appeal, the appellant argues that the Court of Chancery abused its 

discretion and made errors of law in shaping its remedy in this breach of contract 

case between two parties who had a joint venture to market a new drug. As to all 

issues that were fairly raised below, we conclude, with one exception, that the Court 

of Chancery’s rulings were supported by the factual record, within its remedial 

discretion, and consistent with the applicable legal principles. The only argument 

of the appellant that has merit involves a comparatively small issue, given the large 

number of issues that the Vice Chancellor was required to address in his thoughtful 
2

and thorough post-trial decision. That issue involves when pre-judgment interest 

was to begin. The appellee argued for March 2, 2016 as the starting point because 

that was the date when the breach of contract began to impose injury on it.1 Instead 

of hewing to that date, the Court of Chancery imposed pre-judgment interest from 

the time of breach,2even though the appellee itself had argued for a later date and 

did not present evidence that it suffered damages until March 2, 2016, when the 

effects of the breach would have first manifested themselves. Given that the appellee 

did not argue for this date, and given the applicable legal principles, we reverse in 

this minor respect and remand to have the final judgment run pre-judgment interest 

from March 2, 2016, rather than September 15, 2015. In all other respects, we affirm 

the Court of Chancery’s final judgment and order of November 2, 2017 on the basis 

of its well-reasoned opinion of September 19, 2017.

3

BY THE COURT:

/s/ Leo E. Strine, Jr.

Chief Justice 

 

1 App. to Opening Br. at A1787 (Wellstat Therapeutics’ (Corrected) Opening Post-Trial Brief) 

(noting that its damages expert calculated NPV-discounted damages as of the date of breach: 

March 2, 2016).

2 BTG Int’l Inc. v. Wellstat Therapeutics Corp., C.A. No. 12562-VCL, 2017 WL 4151172, at *21 

(Del. Ch. Sept. 19, 2017) (“Interest shall run from September 15, 2015, when BTG first breached 

the Distribution Agreement by failing to provide the Commercial Plan.”).

3

Id.; BTG Int’l Inc. v. Wellstat Therapeutics Corp., C.A. No. 12562-VCL, 2017 WL 5046358 

(Del. Ch. Nov. 2, 2017) (ORDER).
No. 1290.

#### Mancione *v.*Ragen, Warden.

June 10, 1946.

Petition for writ of certiorari to the Criminal Court of Cook County, Illinois, denied.
[No. 53828-4-I.

Division One.

October 24, 2005.]

#### The State of Washington, *Respondent,*v. John D. Travis, *Appellant.*

Appeal from a judgment of the Superior Court for King County, No. 03-1-09036-7, Anthony P. Wartnik, J., entered January 23, 2004. *Affirmed*by unpublished opinion per Baker, J., concurred in by Becker and Schindler, JJ.
Page 29

Exhibit 31.1.  Certification of the Chief Executive Officer

Chief Executive Officer Certification
Pursuant To Section 302 Of 
The Sarbanes-Oxley Act Of 2002

|I, James D. Delamater, certify that:
|------------------------------------
|                                    
|1.                                  
|                                    
|2.                                  
|                                    
|3.                                  
|                                    
|4.                                  
|                                    
|                                    
|                                    
|                                    
|                                    
|                                    
|                                    
|5.                                  
|                                    
|                                    
|                                    
|                                    



|February 10, 2006 | /s/ James D. Delamater 
|----------------- | -----------------------
|                  | James D. Delamater     
|                  | Chief Executive Officer
<PAGE>
 
                                                                   EXHIBIT 10.8a

                       AMENDMENT TO EMPLOYMENT AGREEMENT
                       ---------------------------------

     THAT EMPLOYMENT AGREEMENT ("Agreement") made as of the first day of
November, 1993, by and between THE WISER OIL COMPANY, a Delaware Corporation and
LAWRENCE J. FINN is hereby amended so that Article I, Section 1.02, shall read
as follows:

     1.02 Term.  Subject to the terms and provisions of Article II hereof,
          -----                                                           
     Employee's employment hereunder shall be extended and shall continue
     through the close of business on March 1, 1998 unless extended by
     subsequent agreement of the parties hereto.

     IN WITNESS WHEROF, the parties hereto have executed this Amendment to
Agreement or caused it to be executed as of March 22, 1996.


 
                            /s/  Lawrence J. Finn
                            --------------------------------


                            THE WISER OIL COMPANY

                            By: /s/ Andrew J. Shoup, Jr.
                                -------------------------------------------
                                Title:  President and Chief Executive Officer
                                       ----------------------------------------